Relationship between response to methylphenidate treatment in children with ADHD and psychopathology in their families

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 45, Issue 1, 2006, Pages 47-53

  Grizenko, Natalie ^a   Kovacina, Bojan ^b   Amor, Leila Ben ^a   Schwartz, George ^a   Ter Stepanian, Marina ^a   Joober, Ridha ^a  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Attention deficit hyperactivity disorder; Family psychopathology; Methylphenidate

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FAMILY HISTORY; FEMALE; HEREDITY; HUMAN; INTERVIEW; MALE; MENTAL DISEASE; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOPATHY; RANDOMIZED CONTROLLED TRIAL; RELATIVE; SCHOOL CHILD;

EID: 29144465124     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000184932.64294.d9     Document Type: Article

References (33)

1. American Psychiatric Association (2000), Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association
2. Barkley RA (1990), Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: The Guilford Press
3. Ben Amor L, Grizenko N, Schwartz G et al. (2005), Perinatal complications in children with attention deficit hyperactivity disorder and their unaffected siblings. J Psychiatry Neurosci 30:120-126
4. Biederman J, Faraone SV, Keenan K, Knee D, Tsuang MT (1990), Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 29:526-533
5. Biederman J, Faraone SV, Mick E et al. (1992), Further evidence for family genetic risk factors in attention deficit hyperactivity disorder: patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 49:728-738
6. Braaten EB, Biederman J, Monuteaux MC et al. (2003), Revisiting the association between attention-deficit/hyperactivity disorder and anxiety disorders: a familial risk analysis. Biol Psychiatry 53:93-99
7. Carter CO (1961), The inheritance of congenital pyloric stenosis. Br Med Bull 17:251-254
8. Clark DB, Cornelius J, Wood DS, Vanyukov M (2004), Psychopathology risk transmission in children of parents with substance use disorders. Am J Psychiatry 161:685-691
9. Conners CK (1995), Conners Continuous Performance Test Computer Program. Toronto: MultiHealth Systems
10. Conners CK, Sitarenios G, Parker JD, Epsteins JN (1998a), Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26: 279-291
11. Conners CK, Sitarenios G, Parker JD, Epsteins JN (1998b), The revised Conners Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26:257-268
12. Faraone SV, Biederman J, Mick E et al. (2000), Family study of girls with attention deficit hyperactivity disorder. Am J Psychiatry 157:1077-1083
13. Furukawa Y, Kish SJ (1999), Dopa-responsive dystonia: recent advances and remaining issues to be addressed. Mov Disord 14:709-715
14. Grizenko N, Lachance M, Collard V et al. (2004), Sensitivity of tests to assess improvement in ADHD symptomatology. Can Child Adolesc Rev 13:36-40
15. Hamarman S, Fossella J, Ulger C, Brimacombe M, Dermody J (2004), Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study. J Child Adolesc Psychopharmacol 14:564-574
16. Kirley A, Lowe N, Hawi Z et al. (2003), Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am J Med Genet B Neuropsychiatr Genet 121:50-54
17. Konrad K, Gunter T, Manisch C, Herpertz-Dahlmann B (2004), Differential effects of methylphenidate on attentional function in children with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 43:191-198
18. Lavigne JV, Gibbons RD, Christoffel KK et al. (1996), Prevalence rates and correlates of psychiatric disorders among preschool children. J Am Acad Child Adolesc Psychiatry 35:204-214
19. Lou HC (1996), Etiology and pathogenesis of attention-deficit hyperactivity disorder: significance of prematurity and perinatal hypoxic-haemodynamic encephalopathy. Acta Pediatr 85:1266-1271
20. Low JA, Froese AB, Smith JT, Galbraith RS, Sauerbrei EE, Karchmar EJ (1992), Hypotension and hypoxemia in the preterm newborn during the four days following delivery identify infants at risk of echosonographically demonstrable cerebral lesions. Clin Invest Med 15:60-65
21. McGrath A, Handwerk ML, Armstrong KJ, Lucas CP, Friman PC (2004), The validity of the ADHD section of the Diagnostic Interview Schedule for Children. Behav Modif 28:349-374
22. Maxwell ME (1992), Family Interview for Genetic Studies (FIGS): A Manual for FIGS. Bethesda, MD: Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health
23. Milberger S, Biederman J, Faraone SV, Chen L, Jones J (1996), Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry 153:1138-1142
24. Milich R, Loney J, Landau S (1982), Independent dimensions of hyperactivity and aggression: a validation with playroom observation data. J Abnorm Psychol 91:183-198
25. National Institute for Mental Health (1985), CGI (Clinical Global Impression) Scale. Psychopharmacol Bull 21:839-841
26. Roizen NJ, Blondis TA, Irwin M, Rubinoff A, Kieffer J, Stein M (1996), Psychiatric and developmental disorders in families of children with attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med 150:203-208
27. Roman T, Rohde LA, Hutz MH (2004), Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder. Am J Pharmacogenomics 4:83-92
28. Roy MA, Walsh D, Kendler KS (1996), Accuracies and inaccuracies of the family history method: a multivariate approach. Acta Psychiatr Scand 93:224-234
29. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone, ME (2000), NIMH diagnostic interview schedule for children version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39:28-38
30. Spencer TJ, Biederman J, Wilens TE, Harding M, O'Donnell D, Griffin S (1996), Pharmacotherapy of attention-deficit/hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 34:886-896
31. Spencer TJ, Biederman J, Wilens TE, Faraone SV (2002), Novel treatments for attention-deficit hyperactivity disorder in children. J Clin Psychiatry 63:16-22
32. Spreich S, Biederman J, Harding-Crawford M, Mundy E, Faraone SV (2000), Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 39:1432-1437
33. Wechsler D (1991), Wechsler Intelligence Scale for Children-Third Edition: Manual. San Antonio, TX: The Psychological Corporation